BMT club, Cell and Molecular Biology ClubMonthly discussion club for post-docs
Thursday evenings, Kauppi-cabinet, FM2
see dates and program…
13.2.2012 Kimmo Himberg, PhD, Police College of Finland:
Totuuden jäljillä - rikostutkimuksen kemiaa ja biokemiaa?
The talk will be given in Finnish!
IBT International Seminar Programme on Mondays, FM5 auditorium
seminar program
Related Science News Around The World:
|
|
BioMediTech receives 1,2 million for equipment investments
The Regional Board has granted 1 245 000 euros to the University of Tampere and Tampere University of Technology for a development project of BioMediTech research infrastructure. The funding originates from the European Regional Development Fund (ERDF) and from State co-financing.
The funding enables BioMediTech to procure new equipment for developing new technologies. With the new equipment BioMediTech is expected to increase the amount of innovations and international business in Finland and the Pirkanmaa area. Full cost evaluation of the project is 4,6 million euros. ERDF and State funding are 2,3 million euros and other public funding 2,3 million euros.
Development of BioMediTech is a spearhead project of the Pirkanmaa Regional Programme 2011–2014.
Biodegradable joint implant developed
Tampere University of Technology has developed the world’s first biodegradable joint implant, RegJoint™. The implant is used to treat joint damages caused by osteoarthritis and rheumatoid arthritis. RegJoint™ has now been granted CE marking that enables the selling of the product in the European Union area.
Osteoarthritis and rheumatoid arthritis cause damage to joint cartilage. These are difficult to treat because the regeneration potential of cartilage tissue is limited. The damage makes moving difficult and painful. Until now damaged joints have been treated either by installing permanent implants, or by ossifying.
The biodegradable joint implant offers a new way for treating patients.
Department of Biomedical Engineering is part of BioMediTech, a joint institute of Tampere University of Technology and the University of Tampere.
|
 |
PRESS RELEASE 21.2.2012
For more details please contact:
Professor Minna Kellomäki, Tampere University of Technology, Department of Biomedical Engineering, minna.kellomaki@tut.fi, mobile +358 40 706 6312
Managing Director Tuija Annala, Scaffdex Ltd., tuija.annala@scaffdex.com, mobile +358 40 505 3351 |
|
